Home / Health / Lyft and Allscripts want to make it easier to get people to the doctor’s office

Lyft and Allscripts want to make it easier to get people to the doctor’s office


A Lyft Amp with driver and passenger on January 31, 2017 in San Francisco, California.

Kelly Sullivan | Getty Images

A Lyft Amp with driver and passenger on January 31, 2017 in San Francisco, California.

Lyft and Allscripts are partnering to make it easier for hospitals and doctors’ offices to schedule rides for patients who need them.

The ride-hailing service introduced its concierge platform to health-care providers a little over two years ago so doctors’ offices and hospitals could order transportation for people. It has since inked deals with a number of hospital systems and medical transportation companies.

Allscripts will integrate Lyft’s technology into its electronic medical records system to eliminate the need for someone to manually order rides. When patients schedule appointments, Allscripts’ system will ask if they need transportation.

If they say yes, Allscripts’ system will communicate with Lyft’s to identify the date and time then book the ride. Allscripts CEO Paul Black likens the process to a computer-to-computer handshake.

“It’s very much the next extension of our entrance into health care,” said Lyft’s Chief Business Officer David Baga. “We very much believe it’s going to take a collaborative effort, and we think that this kind of technology integration is going to be a critical path for being successful in terms of breaking down those barriers for access to transportation for the patient community.”

The two companies said they hope working together will reduce the number of people who miss medical appointments because of transportation issues. Patients not showing up can be costly to the health-care system. Offices lose out on revenue, and delaying care can lead to more expensive treatments later on, Black said.

About 3.6 million Americans miss or delay non-emergency medical appointments every year due to such issues, according to a 2005 study published by the National Academy of Sciences.

About admin

Check Also

Big pharma blockbuster obesity drug battle is headed for $100 billion

Ozempic drug to treat diabetes. Courtesy: Ozempic In their most recent earnings reports, Novo Nordisk …